Dec 21, 2016 03:20 AM EST
Gilead HCV Patent Case Against Merck Resolved; Federal Jury Ordered Gilead To Pay Merck
The long running Gilead HCV patent case was resolved after the federal jury penalized Gilead and ordered to pay a multibillion dollar compensation.